229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.17%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-1.09%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
68.57%
EBIT growth above 1.5x VUZI's 11.13%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
68.57%
Operating income growth above 1.5x VUZI's 10.47%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-14.16%
Negative net income growth while VUZI stands at 11.25%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-14.06%
Negative EPS growth while VUZI is at 9.09%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-13.16%
Negative diluted EPS growth while VUZI is at 9.09%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.21%
Share count expansion well above VUZI's 0.33%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-0.60%
Reduced diluted shares while VUZI is at 0.33%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
283.61%
Positive OCF growth while VUZI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
555.88%
Positive FCF growth while VUZI is negative. John Neff would see a strong competitive edge in net cash generation.
2.68%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-46.27%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-18.22%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-40.46%
Negative 10Y OCF/share CAGR while VUZI stands at 60.75%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
782.27%
5Y OCF/share CAGR above 1.5x VUZI's 51.30%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
188.42%
3Y OCF/share CAGR above 1.5x VUZI's 12.89%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
28.19%
Net income/share CAGR at 75-90% of VUZI's 33.50%. Bill Ackman would press for strategic moves to boost long-term earnings.
47.20%
5Y net income/share CAGR above 1.5x VUZI's 14.04%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
399.37%
3Y net income/share CAGR above 1.5x VUZI's 36.24%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
112.81%
Positive growth while VUZI is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
11.94%
Positive 5Y equity/share CAGR while VUZI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
171.78%
Positive short-term equity growth while VUZI is negative. John Neff sees a strong advantage in near-term net worth buildup.
-100.00%
Cut dividends over 10 years while VUZI stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while VUZI stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
2.87%
Our AR growth while VUZI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-50.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.07%
Negative asset growth while VUZI invests at 3.19%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.14%
We have a declining book value while VUZI shows 2.76%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
5.43%
We increase R&D while VUZI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-3.14%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.
